Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Immix Biopharma, Inc. (IMMX) had Return on Equity of -47.35% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.54M |
|
-- |
|
-- |
|
$4.68M |
|
$-4.68M |
|
$0.15M |
|
$-4.53M |
|
$-4.53M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.68M |
|
$-4.62M |
|
29.70M |
|
29.70M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$16.78M |
|
$2.12M |
|
$3.11M |
|
$19.89M |
|
$9.31M |
|
-- |
|
$0.99M |
|
$10.30M |
|
$9.59M |
|
$9.59M |
|
$9.59M |
|
27.85M |
|
| Cash Flow Statement Financials | |
$-1.69M |
|
$-0.07M |
|
-- |
|
$17.68M |
|
$15.92M |
|
$-1.76M |
|
$0.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.75M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-47.35% |
-47.35% |
|
-22.84% |
|
-47.35% |
|
$0.34 |
|
$-0.06 |
|
$-0.06 |
|